Published in

Wiley, FEBS Journal, 2(280), p. 751-765, 2012

DOI: 10.1111/j.1742-4658.2012.08522.x

Links

Tools

Export citation

Search in Google Scholar

Signalling by protein phosphatases and drug development: a systems-centred view

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Protein-modification cycles catalysed by opposing enzymes, such as kinases and phosphatases form the backbone of signalling networks. Whereas historically, kinases have been at the research forefront, a systems-centred approach reveals predominant roles of phosphatases in controlling the network response times and the spatiotemporal profiles of signalling activities. Emerging evidence suggests that phosphatase kinetics are critical for the network function and cell-fate decisions. Protein phosphatases can operate as both immediate and delayed regulators of signal transduction, capable of attenuating or amplifying signalling. This versatility of phosphatase action emphasises the need for systems biology approaches to comprehend cellular signalling networks and predict the cellular outcomes of combinatorial drug interventions.